ReviewTherapeutic advances in hematology2016
The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia.
Kruti Sheth Nair et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papertrialcites it